We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

237 hedge funds and large institutions have $517M invested in Editas Medicine in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $8.36M | Put options by funds: $4.83M

56% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 48

35% more capital invested

Capital invested by funds: $384M → $517M (+$133M)

10% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 39

1% more funds holding

Funds holding: 234 → 237 (+3)

1.04% more ownership

Funds ownership: 76% → 77.04% (+1%)

Holders
237
Holders Change
+3
Holders Change %
+1.28%
% of All Funds
3.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
75
Reduced
48
Closed
39
Calls
$8.36M
Puts
$4.83M
Net Calls
+$3.53M
Net Calls Change
+$2.39M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$30.1M
2
APM
Avidity Partners Management
Texas
+$26.1M
3
Marshall Wace
Marshall Wace
United Kingdom
+$24.7M
4
GCM
Ghisallo Capital Management
Massachusetts
+$8.49M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.39M

Top Sellers

1
State Street
State Street
Massachusetts
-$13.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$11.2M
3
PHS
PFM Health Sciences
California
-$5.22M
4
Bank of America
Bank of America
North Carolina
-$4.48M
5
Citigroup
Citigroup
New York
-$3.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
76
Cubist Systematic Strategies
Connecticut
$449K -$3.18M -364,591 -87%
HIS
77
Harvest Investment Services
Illinois
$442K +$468K +53,727 New
BC
78
Bridgefront Capital
Texas
$439K +$197K +22,601 +74%
PMEF
79
Point72 Middle East FZE
United Arab Emirates
$399K +$206K +23,653 +95%
RJFSA
80
Raymond James Financial Services Advisors
Florida
$393K +$20.7K +2,380 +5%
HI
81
HBK Investments
Texas
$329K +$348K +40,000 New
KWILP
82
Kiwi Wealth Investments Limited Partnership
New Zealand
$315K – – –
MIM
83
MetLife Investment Management
New Jersey
$306K – – –
T. Rowe Price Associates
84
T. Rowe Price Associates
Maryland
$294K +$5.11K +586 +2%
American Century Companies
85
American Century Companies
Missouri
$283K +$147K +16,827 +96%
CANY
86
Caxton Associates (New York)
New York
$276K -$646K -74,163 -69%
AIG
87
American International Group
New York
$276K +$1.44K +165 +0.5%
VF
88
Virtu Financial
New York
$275K +$291K +33,355 New
GCM
89
Graham Capital Management
Connecticut
$272K +$288K +33,088 New
HKAM
90
Horizon Kinetics Asset Management
New York
$272K – – –
PNC Financial Services Group
91
PNC Financial Services Group
Pennsylvania
$254K -$627 -72 -0.2%
EFM
92
E Fund Management
China
$254K -$69.1K -7,932 -20%
Janus Henderson Group
93
Janus Henderson Group
United Kingdom
$251K -$322 -37 -0.1%
Royal Bank of Canada
94
Royal Bank of Canada
Ontario, Canada
$242K +$62.6K +7,188 +32%
Mitsubishi UFJ Asset Management
95
Mitsubishi UFJ Asset Management
Japan
$242K +$40.8K +4,678 +19%
WM
96
WS Management
Florida
$237K – – –
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$231K +$9.39K +1,078 +4%
AQR Capital Management
98
AQR Capital Management
Connecticut
$229K -$248K -28,433 -51%
MML Investors Services
99
MML Investors Services
Massachusetts
$227K +$79.8K +9,157 +50%
VOYA Investment Management
100
VOYA Investment Management
Georgia
$226K +$7.18K +824 +3%
2 3
4
5 6

EDIT Hedge Fund Activity: Q2 2023 in Review

237 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2023, worth a combined $517M — up 35% from $384M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new EDIT positions and 39 closed out — a net gain of 4 holders — while 75 added to existing stakes and 48 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $30.1M. The largest seller was State Street, cutting an estimated $13.3M.

  • 237 institutional investors held Editas Medicine (EDIT) as of Q2 2023, up from 234 in Q1 2023.
  • Funds reported $517M of Editas Medicine stock for Q2 2023, up 35% quarter-over-quarter.
  • 43 funds opened new Editas Medicine positions in Q2 2023 and 39 closed out, a net change of +4 holders.
  • The largest Editas Medicine buyer in Q2 2023 was Deep Track Capital, an estimated $30.1M added.
  • The largest Editas Medicine seller in Q2 2023 was State Street, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2023.